(“Dear God, please let the lab lose my sample.” / Photo via MMAJunkie)
Recent flyweight title challenger Ali Bagautinov has been suspended for one year following a positive test for erythropoietin (EPO), a unapproved hormone that increases red blood cell production. (See also: Lance Armstrong, Chael Sonnen.) The British Columbia Athletic Commission on Thursday confirmed the news today.
Bagautinov failed a random drug test that was administered on June 2nd, 12 days before his unanimous decision loss to Demetrious Johnson at UFC 174 in Vancouver. As BCAC Commissioner Dave Maedel explained (via MMAJunkie):
“These results were not available prior to the UFC 174 event due to lab processing times…I have suspended Mr. Bagautinov’s licence to compete in British Columbia for a period of one year.”
So not only was UFC 174 the poorest-selling PPV in nine years, it also produced one more victim of MMA’s newest supervillain — the random drug-test. Seriously, increased drug testing is wiping out high-profile fighters left and right lately, which tells you all you need to know about how widespread the doping problem is in this sport. Keep fighting the good fight, athletic commissions.